Essex, LLC
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANVS.NYSE | Annovis Bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.128 | 0.037 | 10.4k | $3.7k | $20.5k |
| |||||||||||||
ANVS.NYSE MKT | ANVS.NYSE MKT | - | - | - | - | 0.128 | 0.037 | 10.4k | - | - | ||||||||||||||
ICAD.NASDAQ | icad inc | USA | Healthcare | Medical Devices | 2024-09-30 | 0.522 | 0.053 | 137.5k | $153.3k | $349.2k |
| |||||||||||||
TMDI.NASDAQ | TMDI.NASDAQ | - | - | - | - | 2.554 | 0.571 | 2.8m | - | - |
Trades
Buys
Report date: 2024-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ICAD.NASDAQ | 137.9k | - | 197.8k | 1-2 | $2.54 | 115.3% |
Adds
Report date: 2022-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
TMDI.NASDAQ | 493.4k | 20.9 | 0.00 | 0-0 | - | - |
Report date: 2022-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
TMDI.NASDAQ | 359.5k | 17.9 | 186.3k | 0-1 | - | - |
Report date: 2022-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
ANVS.NYSE MKT | 12.5k | 118.9 | 182.5k | 12-20 | - | - |
Reduces
Report date: 2024-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ICAD.NASDAQ | -450.00 | -0.3 | -797.24 | 1-2 | $2.54 | 90.3% |
Report date: 2022-06-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ANVS.NYSE | -12.7k | -55.1 | -140.7k | 8-15 | $1.97 | -76.5% |
ANVS.NYSE MKT | -12.7k | -55.1 | -140.7k | 8-15 | - | - |
TMDI.NASDAQ | -1.2m | -38.7 | -621k | 0-1 | - | - |
Comments
How you think about this?